~Lindsay Krause Blackwood, Sanjiv Arora Assume Executive Leadership
Roles~
PLANO, TEXAS – April 8, 2025 – Integer Holdings Corporation (NYSE: ITGR), one of the largest
medical device contract development and manufacturing organizations (CDMO)
in the world, today announced the addition of two Executive Leadership Team
(ELT) members – Lindsay Krause Blackwood and Sanjiv Arora. Both
individuals will report to Integer President and CEO Joe Dziedzic.
Lindsay Krause Blackwood
succeeds Mac Marshall, who retired at the end of March 2025, as
Integer’s Senior Vice President, General Counsel, Chief Ethics and
Compliance Officer and Corporate Secretary. Prior to joining Integer,
Lindsay was Executive Vice President, General Counsel, Chief Compliance
Officer and Corporate Secretary for The Brink’s Company. She also held
a variety of legal leadership roles at Cigna Corporation, associate counsel
roles at Verizon Business (formerly known as MCI, Inc.) and began her career
as a law firm associate at Shaw Pittman (now Pillsbury Winthrop Shaw
Pittman) and Gibson Dunn & Crutcher. Lindsay holds a Juris Doctor (J.D.)
and a Bachelor of Arts in History from the University of Virginia. She is a
member of the Virginia State Bar and the District of Columbia Bar.
Sanjiv Arora
joins Integer as Senior Vice President, Strategy, Business Development and
Investor Relations as a result of Andrew Senn’s recent promotion to
President of Integer’s Cardio & Vascular business. Prior to
joining Integer, Sanjiv was Senior Vice President, Chief Strategy and
Corporate Development Officer for Solventum, a 3M Health Care business
spin-off. He previously held senior leadership roles at Medtronic, Edwards
Lifesciences, Covidien and Boston Scientific. He was also a Managing
Director focused on healthcare technology research, life sciences and
medical technology investments at Cargill and RBC Capital Markets. Sanjiv
holds a Master of Business Administration from Duke University's Fuqua
School of Business and a Bachelor of Science in Chemical Engineering from
the University of Minnesota.
“I’m thrilled to welcome these two exemplary leaders to
Integer’s Executive Leadership Team,” said Dziedzic.
“Their collective experience and critical knowledge of the medical
device industry not only complement our existing ELT, but further enhance
our expertise in corporate strategy and governance, M&A and enterprise
risk management, all of which are critical as we continue to execute on our
strategy.”
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical
device contract development and manufacturing organizations (CDMO) in the
world, serving the cardiac rhythm management, neuromodulation, and cardio
and vascular markets. As a strategic partner of choice to medical device
companies and OEMs, the Company is committed to enhancing the lives of
patients worldwide by providing innovative, high-quality products and
solutions. The Company's brands include Greatbatch Medical® and Lake
Region Medical®. Additional information is available at www.integer.net.